SlideShare ist ein Scribd-Unternehmen logo
1 von 26
Lower Esophageal Sphincter
  Augmentation With Linx

    Advances in Technology and
 Understanding of Esophageal Disease

         January 11, 2013
    Mayo Clinic Education Center
         Phoenix, Arizona

        C. Daniel Smith, MD
                                       1
Conflict of Interest / Disclosures


- Co-PI for one of the sites who participated
 in the Pivotal Trial

- Advisor/consultant to Torax for preparation
 of the presentation to FDA

- Joined company for presentation to FDA
- Paid consultant to company helping with
 safe and successful introduction of Linx to
 care of GERD patients

                                                  2
Fundoplication


• Great operation
• Select patients do very well
• Superior to PPIs
• Significant positive impact on natural history
  of GERD
• Multiple studies have confirmed its
  effectiveness and role in treatment of GERD

                                                   3
GERD - Current Treatment Options

                                         Fundoplication Surgery

                                PPI Therapy PPI Therapy




                                                                             Fundoplication
                                                                             Surgery
st ne t a P DRE G. o N




                                  Severity of Symptoms and Dissatisfaction
    i




                         Mild                                                  Severe



                                                                                              4
Fundoplication

• Use of fundoplication for GERD has
  peaked, use slowly declining

• GIs have largely stopped referring patients
  except for desperate or complicated cases

• Most cases are done for complicated conditions
  (redo, large hiatal hernia, Barretts, severe
  refractory GERD

• PPIs remain treatment of choice for all but the
  most severe cases of GERD
                                                    5
Fundoplication – Why Not?

• Technical failures – inconsistent and
  questionable outcomes
• Lack of standardized approach/technique
• Inconsistent use – patients still have fundoplication
  performed without objective confirmation of GERD
• Patients are afraid of the operation – troubling side-
  effects of gas bloat and excess flatus or perception
  that failure rate is 50%
• Competing treatments – primarily PPIs, some
  endolumenal approaches
                                                           6
GERD - Current Treatment Options
                                No standard treatment for Gap patients

                                  PPI Therapy                                  Targeted Linx
                                                                                population

                                                                         Therapy Gap
                                                                                        Fundoplication
                                                                                        Surgery
st ne t a P DRE G. o N




                                    Severity of Symptoms and Dissatisfaction
    i




                         Mild                                                              Severe



                                                                                                         7
Linx




FDA Approved March 2012 - PMA
                                8
Torax Medical




                9
Linx




       10
Linx – Barium Swallow




                        11
Linx – Procedure




                   12
Linx




LINX   Fibrous
Bead   Capsule




        In-tact
       Muscular
         Layer

       Mucosa




           13
Clinical Studies - Linx




                          14
Median Acid Exposure - Linx



n=100




                     P<0.001



                       n=96




                                      15
Median GERD-HRQL - Linx




n=100
                       P<0.001


        n=100


                n=95   n=90      n=85




                                        16
Heartburn - Linx


        - Interfere with activities of daily living
           - Primary reason for visit

n=100




                                               P<0.001




                                                         n=84
                n=95                    n=90




                                                                17
Regurgitation - Linx


        - Constant regurgitation, presence of aspiration
           - Predictable with position change




n=100

                                           P<0.001




               n=95                 n=90                   n=84




                                                                  18
PPI Use - Linx



n=100




                      P<0.001




        n=95   n=90             n=84




                                       19
Time Course of Dysphagia - Linx




                                  20
Patient Satisfaction - Linx



        n=95                n=84
                 n=90



                                   P<0.001




n=100




                                        21
Gas Bloat - Linx




                      P<0.001

n=100




        n=95   n=90         n=84




                                   22
Serious Adverse Event - Linx

 Subject ID          Event                   Description                           Status

03-005-004    Dysphagia      Explanted 31 days after implant            Resolved
              Nausea

03-004-004    Dysphagia      Explanted 93 days after implant            Resolved
              Odynophagia

03-008-021    Dysphagia      Explanted 21 days after implant            Resolved


03-008-018    Pain           Hospitalized for pain;                     Resolved (pain)

              Vomiting       Explanted 357 days after implant for       Ongoing, no follow-up
                             vomiting                                   deemed necessary
                                                                        (vomiting)


03-008-020    Vomiting       Hospitalized 2 days after implant for <2   Resolved
                             days

03-018-002    Nausea         Hospitalized 2 days after implant for <2   Resolved
                             days


                     No device migration or erosion
                                                                                                23
The Successful LINX Patient
                                                               Post-LINX
Baseline
                                                               % of Pts
% of Pts                    Characteristic
                                                                3 Years
 100%      Daily PPI dependence                                   8%

 70%       Reflux affecting their sleep on a daily basis          2%

 76%       Reflux affecting their food tolerances on a daily      2%
           basis
 57%       Moderate or severe regurgitation including             1%
           aspirations
 55%       Severe heartburn affecting their daily life            1%

 51%       Experiencing extra esophageal symptoms in             12%
           addition to heartburn and/or regurgitation
 40%       Esophagitis                                           11%
Patient Selection - Linx

                          INDICATION
    The LINX Reflux Management System is indicated for patients
    diagnosed with GERD as defined by abnormal pH testing, who
     continue to have chronic GERD symptoms despite maximum
             medical therapy for the treatment of reflux.




• Age 18 +                        • No active esophagitis > grade b
• Hiatal hernia < 3cm             • No Barrett’s
• Normal esophageal motility      • BMI < 35
Summary / Conclusion - Linx

• Device closely reproduces native LES
  function - dynamic

• Improvement over current surgical options

• Addresses a significant unmet need

• Positively transforms patients’ lives

• LINX would be a tremendous positive
  addition to current options for GERD
                                               27

Weitere ähnliche Inhalte

Andere mochten auch

Recent advances in pancreatic cancer
Recent advances in pancreatic cancerRecent advances in pancreatic cancer
Recent advances in pancreatic cancerKaushik Kumar Eswaran
 
Recent advances in burns management by Dr. Sunil Keswani, National Burns Cent...
Recent advances in burns management by Dr. Sunil Keswani, National Burns Cent...Recent advances in burns management by Dr. Sunil Keswani, National Burns Cent...
Recent advances in burns management by Dr. Sunil Keswani, National Burns Cent...NationalBurnsCentre2000
 
Melanoma clinical features, pathology and management
Melanoma clinical features, pathology and managementMelanoma clinical features, pathology and management
Melanoma clinical features, pathology and managementsanyal1981
 
Excretion Urography / Intravenous Urography (IVU)
Excretion Urography / Intravenous Urography (IVU)Excretion Urography / Intravenous Urography (IVU)
Excretion Urography / Intravenous Urography (IVU)Sudil Paudyal
 
Pilonidal sinus defect closure, reconstruction methods
Pilonidal sinus defect closure, reconstruction methodsPilonidal sinus defect closure, reconstruction methods
Pilonidal sinus defect closure, reconstruction methodsAhmed Almumtin
 
Upper Gastrointestinal bleeding
Upper Gastrointestinal bleedingUpper Gastrointestinal bleeding
Upper Gastrointestinal bleedingAmmar L. Aldwaf
 

Andere mochten auch (10)

SLNB
SLNBSLNB
SLNB
 
Recent advances in pancreatic cancer
Recent advances in pancreatic cancerRecent advances in pancreatic cancer
Recent advances in pancreatic cancer
 
Recent advances in burns management by Dr. Sunil Keswani, National Burns Cent...
Recent advances in burns management by Dr. Sunil Keswani, National Burns Cent...Recent advances in burns management by Dr. Sunil Keswani, National Burns Cent...
Recent advances in burns management by Dr. Sunil Keswani, National Burns Cent...
 
Melanoma clinical features, pathology and management
Melanoma clinical features, pathology and managementMelanoma clinical features, pathology and management
Melanoma clinical features, pathology and management
 
Excretion Urography / Intravenous Urography (IVU)
Excretion Urography / Intravenous Urography (IVU)Excretion Urography / Intravenous Urography (IVU)
Excretion Urography / Intravenous Urography (IVU)
 
Intravenous urography (IVU)
Intravenous urography (IVU)Intravenous urography (IVU)
Intravenous urography (IVU)
 
Pilonidal sinus
Pilonidal sinusPilonidal sinus
Pilonidal sinus
 
Pilonidal sinus defect closure, reconstruction methods
Pilonidal sinus defect closure, reconstruction methodsPilonidal sinus defect closure, reconstruction methods
Pilonidal sinus defect closure, reconstruction methods
 
Burns management
Burns managementBurns management
Burns management
 
Upper Gastrointestinal bleeding
Upper Gastrointestinal bleedingUpper Gastrointestinal bleeding
Upper Gastrointestinal bleeding
 

Ähnlich wie Advances in Managing GERD - LINX

Appendicle abscess Siedah Telesford MDDr. Griffith Team .docx
Appendicle abscess Siedah Telesford MDDr. Griffith Team .docxAppendicle abscess Siedah Telesford MDDr. Griffith Team .docx
Appendicle abscess Siedah Telesford MDDr. Griffith Team .docxrossskuddershamus
 
Latest presentation on endoluminal anti-reflux surgery with Esophyx
Latest presentation on endoluminal anti-reflux surgery with Esophyx Latest presentation on endoluminal anti-reflux surgery with Esophyx
Latest presentation on endoluminal anti-reflux surgery with Esophyx Ben Gurion University of the Negev
 
Breakout 1.1 - Dr Kerri Jones
Breakout 1.1 - Dr Kerri JonesBreakout 1.1 - Dr Kerri Jones
Breakout 1.1 - Dr Kerri JonesNHS Improvement
 
Day care surgery
Day care surgeryDay care surgery
Day care surgerySufindc
 
Management of traumatic brain injury
Management of traumatic brain injuryManagement of traumatic brain injury
Management of traumatic brain injuryDr.Anand Tiwari
 
Div disease dukes club
Div disease dukes clubDiv disease dukes club
Div disease dukes clubthedukes
 
Day care laparoscopic surgery in pediatrics
Day care laparoscopic surgery in pediatricsDay care laparoscopic surgery in pediatrics
Day care laparoscopic surgery in pediatricsPRAKASH AGARWAL
 
4 kahi lower gi
4 kahi lower gi4 kahi lower gi
4 kahi lower giangel4567
 
Managing Pain in Ca. Pancreas - Dr. Vijayanand
Managing Pain in Ca. Pancreas - Dr. VijayanandManaging Pain in Ca. Pancreas - Dr. Vijayanand
Managing Pain in Ca. Pancreas - Dr. Vijayanandmedicovibes
 
Painful Challenges in Neurology.pptx
Painful Challenges in Neurology.pptxPainful Challenges in Neurology.pptx
Painful Challenges in Neurology.pptxPramod Krishnan
 
Post operative care
Post operative care Post operative care
Post operative care leohome
 
Heartburn and Acid Reflux: Causes & New Treatment Options
Heartburn and Acid Reflux: Causes & New Treatment OptionsHeartburn and Acid Reflux: Causes & New Treatment Options
Heartburn and Acid Reflux: Causes & New Treatment OptionsAffinity Health System
 
anaesthesiaforivf-171213035409.pptx
anaesthesiaforivf-171213035409.pptxanaesthesiaforivf-171213035409.pptx
anaesthesiaforivf-171213035409.pptxvinitha239658
 
Tons slides-2003-1105
Tons slides-2003-1105Tons slides-2003-1105
Tons slides-2003-1105Ansa Poudel
 
Radiotherapy techniques, indications and evidences in oral cavity and oropha...
Radiotherapy techniques, indications and evidences  in oral cavity and oropha...Radiotherapy techniques, indications and evidences  in oral cavity and oropha...
Radiotherapy techniques, indications and evidences in oral cavity and oropha...Dr.Amrita Rakesh
 
Management of thyroid eye disease
Management of thyroid eye diseaseManagement of thyroid eye disease
Management of thyroid eye diseaseSiva G
 
Anaesthesia for ivf
Anaesthesia  for ivfAnaesthesia  for ivf
Anaesthesia for ivfPriti Patil
 

Ähnlich wie Advances in Managing GERD - LINX (20)

Appendicle abscess Siedah Telesford MDDr. Griffith Team .docx
Appendicle abscess Siedah Telesford MDDr. Griffith Team .docxAppendicle abscess Siedah Telesford MDDr. Griffith Team .docx
Appendicle abscess Siedah Telesford MDDr. Griffith Team .docx
 
Latest presentation on endoluminal anti-reflux surgery with Esophyx
Latest presentation on endoluminal anti-reflux surgery with Esophyx Latest presentation on endoluminal anti-reflux surgery with Esophyx
Latest presentation on endoluminal anti-reflux surgery with Esophyx
 
Breakout 1.1 - Dr Kerri Jones
Breakout 1.1 - Dr Kerri JonesBreakout 1.1 - Dr Kerri Jones
Breakout 1.1 - Dr Kerri Jones
 
Day care surgery
Day care surgeryDay care surgery
Day care surgery
 
Management of traumatic brain injury
Management of traumatic brain injuryManagement of traumatic brain injury
Management of traumatic brain injury
 
Div disease dukes club
Div disease dukes clubDiv disease dukes club
Div disease dukes club
 
Day care laparoscopic surgery in pediatrics
Day care laparoscopic surgery in pediatricsDay care laparoscopic surgery in pediatrics
Day care laparoscopic surgery in pediatrics
 
Endo emergency
Endo emergencyEndo emergency
Endo emergency
 
4 kahi lower gi
4 kahi lower gi4 kahi lower gi
4 kahi lower gi
 
Managing Pain in Ca. Pancreas - Dr. Vijayanand
Managing Pain in Ca. Pancreas - Dr. VijayanandManaging Pain in Ca. Pancreas - Dr. Vijayanand
Managing Pain in Ca. Pancreas - Dr. Vijayanand
 
Painful Challenges in Neurology.pptx
Painful Challenges in Neurology.pptxPainful Challenges in Neurology.pptx
Painful Challenges in Neurology.pptx
 
Post operative care
Post operative care Post operative care
Post operative care
 
Heartburn and Acid Reflux: Causes & New Treatment Options
Heartburn and Acid Reflux: Causes & New Treatment OptionsHeartburn and Acid Reflux: Causes & New Treatment Options
Heartburn and Acid Reflux: Causes & New Treatment Options
 
anaesthesiaforivf-171213035409.pptx
anaesthesiaforivf-171213035409.pptxanaesthesiaforivf-171213035409.pptx
anaesthesiaforivf-171213035409.pptx
 
Chronic Opioid Therapy
Chronic Opioid TherapyChronic Opioid Therapy
Chronic Opioid Therapy
 
Tons slides-2003-1105
Tons slides-2003-1105Tons slides-2003-1105
Tons slides-2003-1105
 
Radiotherapy techniques, indications and evidences in oral cavity and oropha...
Radiotherapy techniques, indications and evidences  in oral cavity and oropha...Radiotherapy techniques, indications and evidences  in oral cavity and oropha...
Radiotherapy techniques, indications and evidences in oral cavity and oropha...
 
Management of thyroid eye disease
Management of thyroid eye diseaseManagement of thyroid eye disease
Management of thyroid eye disease
 
Anaesthesia for ivf
Anaesthesia  for ivfAnaesthesia  for ivf
Anaesthesia for ivf
 
Adenoidectomy
AdenoidectomyAdenoidectomy
Adenoidectomy
 

Mehr von C Daniel Smith

Operating Room Design - Mayo Case Study
Operating Room Design - Mayo Case StudyOperating Room Design - Mayo Case Study
Operating Room Design - Mayo Case StudyC Daniel Smith
 
Early Results With Linx and Lessons for Implementation in Practice
Early Results With Linx and Lessons for Implementation in PracticeEarly Results With Linx and Lessons for Implementation in Practice
Early Results With Linx and Lessons for Implementation in PracticeC Daniel Smith
 
SureSELECT - Operating Room and Hospital Resource Utilization Schedule Optimi...
SureSELECT - Operating Room and Hospital Resource Utilization Schedule Optimi...SureSELECT - Operating Room and Hospital Resource Utilization Schedule Optimi...
SureSELECT - Operating Room and Hospital Resource Utilization Schedule Optimi...C Daniel Smith
 
Re-engineering the Operating Room Using Variability Methodology to Improve He...
Re-engineering the Operating Room Using Variability Methodology to Improve He...Re-engineering the Operating Room Using Variability Methodology to Improve He...
Re-engineering the Operating Room Using Variability Methodology to Improve He...C Daniel Smith
 
Improving Surgical Safety and Patient Outcomes
Improving Surgical Safety and Patient OutcomesImproving Surgical Safety and Patient Outcomes
Improving Surgical Safety and Patient OutcomesC Daniel Smith
 
SureSELECT from PureFLOW-HC
SureSELECT from PureFLOW-HCSureSELECT from PureFLOW-HC
SureSELECT from PureFLOW-HCC Daniel Smith
 
Innovations in Foregut Surgery
Innovations in Foregut SurgeryInnovations in Foregut Surgery
Innovations in Foregut SurgeryC Daniel Smith
 
Innovations in Minimally Invasive Surgery 2011
Innovations in Minimally Invasive Surgery 2011Innovations in Minimally Invasive Surgery 2011
Innovations in Minimally Invasive Surgery 2011C Daniel Smith
 
Failed Fundoplication Surgery
Failed Fundoplication SurgeryFailed Fundoplication Surgery
Failed Fundoplication SurgeryC Daniel Smith
 
Achalasia Surgery Update 2012
Achalasia Surgery Update 2012Achalasia Surgery Update 2012
Achalasia Surgery Update 2012C Daniel Smith
 
FDA Advisory Panel Linx Presentation 011112
FDA Advisory Panel Linx Presentation 011112FDA Advisory Panel Linx Presentation 011112
FDA Advisory Panel Linx Presentation 011112C Daniel Smith
 

Mehr von C Daniel Smith (13)

Operating Room Design - Mayo Case Study
Operating Room Design - Mayo Case StudyOperating Room Design - Mayo Case Study
Operating Room Design - Mayo Case Study
 
Early Results With Linx and Lessons for Implementation in Practice
Early Results With Linx and Lessons for Implementation in PracticeEarly Results With Linx and Lessons for Implementation in Practice
Early Results With Linx and Lessons for Implementation in Practice
 
SureSELECT - Operating Room and Hospital Resource Utilization Schedule Optimi...
SureSELECT - Operating Room and Hospital Resource Utilization Schedule Optimi...SureSELECT - Operating Room and Hospital Resource Utilization Schedule Optimi...
SureSELECT - Operating Room and Hospital Resource Utilization Schedule Optimi...
 
Re-engineering the Operating Room Using Variability Methodology to Improve He...
Re-engineering the Operating Room Using Variability Methodology to Improve He...Re-engineering the Operating Room Using Variability Methodology to Improve He...
Re-engineering the Operating Room Using Variability Methodology to Improve He...
 
Improving Surgical Safety and Patient Outcomes
Improving Surgical Safety and Patient OutcomesImproving Surgical Safety and Patient Outcomes
Improving Surgical Safety and Patient Outcomes
 
SureSELECT from PureFLOW-HC
SureSELECT from PureFLOW-HCSureSELECT from PureFLOW-HC
SureSELECT from PureFLOW-HC
 
Innovations in Foregut Surgery
Innovations in Foregut SurgeryInnovations in Foregut Surgery
Innovations in Foregut Surgery
 
Innovations in Minimally Invasive Surgery 2011
Innovations in Minimally Invasive Surgery 2011Innovations in Minimally Invasive Surgery 2011
Innovations in Minimally Invasive Surgery 2011
 
Failed Fundoplication Surgery
Failed Fundoplication SurgeryFailed Fundoplication Surgery
Failed Fundoplication Surgery
 
Achalasia Surgery Update 2012
Achalasia Surgery Update 2012Achalasia Surgery Update 2012
Achalasia Surgery Update 2012
 
New Offering for GERD
New Offering for GERDNew Offering for GERD
New Offering for GERD
 
FDA Advisory Panel Linx Presentation 011112
FDA Advisory Panel Linx Presentation 011112FDA Advisory Panel Linx Presentation 011112
FDA Advisory Panel Linx Presentation 011112
 
Paetau mie 090211
Paetau mie 090211Paetau mie 090211
Paetau mie 090211
 

Advances in Managing GERD - LINX

  • 1. Lower Esophageal Sphincter Augmentation With Linx Advances in Technology and Understanding of Esophageal Disease January 11, 2013 Mayo Clinic Education Center Phoenix, Arizona C. Daniel Smith, MD 1
  • 2. Conflict of Interest / Disclosures - Co-PI for one of the sites who participated in the Pivotal Trial - Advisor/consultant to Torax for preparation of the presentation to FDA - Joined company for presentation to FDA - Paid consultant to company helping with safe and successful introduction of Linx to care of GERD patients 2
  • 3. Fundoplication • Great operation • Select patients do very well • Superior to PPIs • Significant positive impact on natural history of GERD • Multiple studies have confirmed its effectiveness and role in treatment of GERD 3
  • 4. GERD - Current Treatment Options Fundoplication Surgery PPI Therapy PPI Therapy Fundoplication Surgery st ne t a P DRE G. o N Severity of Symptoms and Dissatisfaction i Mild Severe 4
  • 5. Fundoplication • Use of fundoplication for GERD has peaked, use slowly declining • GIs have largely stopped referring patients except for desperate or complicated cases • Most cases are done for complicated conditions (redo, large hiatal hernia, Barretts, severe refractory GERD • PPIs remain treatment of choice for all but the most severe cases of GERD 5
  • 6. Fundoplication – Why Not? • Technical failures – inconsistent and questionable outcomes • Lack of standardized approach/technique • Inconsistent use – patients still have fundoplication performed without objective confirmation of GERD • Patients are afraid of the operation – troubling side- effects of gas bloat and excess flatus or perception that failure rate is 50% • Competing treatments – primarily PPIs, some endolumenal approaches 6
  • 7. GERD - Current Treatment Options No standard treatment for Gap patients PPI Therapy Targeted Linx population Therapy Gap Fundoplication Surgery st ne t a P DRE G. o N Severity of Symptoms and Dissatisfaction i Mild Severe 7
  • 8. Linx FDA Approved March 2012 - PMA 8
  • 10. Linx 10
  • 11. Linx – Barium Swallow 11
  • 13. Linx LINX Fibrous Bead Capsule In-tact Muscular Layer Mucosa 13
  • 15. Median Acid Exposure - Linx n=100 P<0.001 n=96 15
  • 16. Median GERD-HRQL - Linx n=100 P<0.001 n=100 n=95 n=90 n=85 16
  • 17. Heartburn - Linx - Interfere with activities of daily living - Primary reason for visit n=100 P<0.001 n=84 n=95 n=90 17
  • 18. Regurgitation - Linx - Constant regurgitation, presence of aspiration - Predictable with position change n=100 P<0.001 n=95 n=90 n=84 18
  • 19. PPI Use - Linx n=100 P<0.001 n=95 n=90 n=84 19
  • 20. Time Course of Dysphagia - Linx 20
  • 21. Patient Satisfaction - Linx n=95 n=84 n=90 P<0.001 n=100 21
  • 22. Gas Bloat - Linx P<0.001 n=100 n=95 n=90 n=84 22
  • 23. Serious Adverse Event - Linx Subject ID Event Description Status 03-005-004 Dysphagia Explanted 31 days after implant Resolved Nausea 03-004-004 Dysphagia Explanted 93 days after implant Resolved Odynophagia 03-008-021 Dysphagia Explanted 21 days after implant Resolved 03-008-018 Pain Hospitalized for pain; Resolved (pain) Vomiting Explanted 357 days after implant for Ongoing, no follow-up vomiting deemed necessary (vomiting) 03-008-020 Vomiting Hospitalized 2 days after implant for <2 Resolved days 03-018-002 Nausea Hospitalized 2 days after implant for <2 Resolved days No device migration or erosion 23
  • 24. The Successful LINX Patient Post-LINX Baseline % of Pts % of Pts Characteristic 3 Years 100% Daily PPI dependence 8% 70% Reflux affecting their sleep on a daily basis 2% 76% Reflux affecting their food tolerances on a daily 2% basis 57% Moderate or severe regurgitation including 1% aspirations 55% Severe heartburn affecting their daily life 1% 51% Experiencing extra esophageal symptoms in 12% addition to heartburn and/or regurgitation 40% Esophagitis 11%
  • 25. Patient Selection - Linx INDICATION The LINX Reflux Management System is indicated for patients diagnosed with GERD as defined by abnormal pH testing, who continue to have chronic GERD symptoms despite maximum medical therapy for the treatment of reflux. • Age 18 + • No active esophagitis > grade b • Hiatal hernia < 3cm • No Barrett’s • Normal esophageal motility • BMI < 35
  • 26. Summary / Conclusion - Linx • Device closely reproduces native LES function - dynamic • Improvement over current surgical options • Addresses a significant unmet need • Positively transforms patients’ lives • LINX would be a tremendous positive addition to current options for GERD 27

Hinweis der Redaktion

  1. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  2. With this understanding, there have been several key principles that have guided our efforts. These include isolating the unpredicatble variation of the urgent/emergent practice, Natural Variation, from the manageable and modifiably variation of the elective practice, Artificial Variation. Design a process to create a predictable and more consistent surgical schedule, Limit the number of changes we make to the elective schedule on the day of surgery, and maintain the integrtity of our surgical teams so that patients can benefit fomr the expertise and quaity we deliver through our team-based care.
  3. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  4. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  5. With this understanding, there have been several key principles that have guided our efforts. These include isolating the unpredicatble variation of the urgent/emergent practice, Natural Variation, from the manageable and modifiably variation of the elective practice, Artificial Variation. Design a process to create a predictable and more consistent surgical schedule, Limit the number of changes we make to the elective schedule on the day of surgery, and maintain the integrtity of our surgical teams so that patients can benefit fomr the expertise and quaity we deliver through our team-based care.
  6. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  7. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  8. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  9. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  10. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  11. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  12. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  13. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  14. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  15. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  16. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  17. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  18. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  19. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  20. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.
  21. Our goals when deliver healthcare should be to provide the right care, to the right patient, at the right time. It is critical that we do that will maintaining or increasing the value of the healthcare we deliver. In doing this variability is the enemy.